Long-term Safety and Efficacy of GBG Study Participants
Recruiting · NCT05739591 · Observational (researchers observe without assigning treatment) · Lead sponsor: GBG Forschungs GmbH
View the official record on ClinicalTrials.gov →What this trial is about
The ETERNITY study is an international, multicenter, observational study that aims to follow up patients who have participated in a GBG trial for early breast cancer, even after the study has officially ended, in order to collect long-term data on survival, late or delayed adverse events, in addition to information related to pregnancy, fertility and other parameters impacting quality of life.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Participation and treatment in a GBG clinical trial for early breast cancer.
- Prospective registration: Written informed consent according to local regulatory requirements prior to data and biomaterial collection.
Exclusion criteria
- Participation and treatment in a non-GBG clinical trial for early breast cancer.
- Patients with advanced or metastatic breast cancer who have participated and received treatment in a GBG clinical trial.
Where it is running
3 locations listed.
- MUI - Univ. Klinik f. Frauenheilkunde Innsbruck - Innsbruck, Austria
- Ordensklinikum Linz GmbH - BHS - Linz, Austria
- LKH Salzburg - PMU - Salzburg, Austria